One in 15,000 babies are born with a rare brain disorder known as Angelman syndrome. With genetic testing Angelman syndrome can be detected as early as 10 weeks after conceptions, however at present there is no treatment available. Researchers from the University of North Carolina are hoping a gene-editing tool known as Crispr will change this, and provide an effective treatment to babies before they are born. This approach has been effective in mice model, as well as in human brain cells that have been grown in a dish, although human trails have not begun. The researchers believe that this type of early intervention gene therapy will be beneficial for not only Angelman syndrome, but other neurodevelopmental disorders.
Source: The Guardian
Read more: http://ow.ly/EHeq30nNY0f